RESEARCH, COLLABORATION & LICENSE AGREEMENT DATED AS OF MAY 5, 2016 BY AND BETWEEN THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA AND DIMENSION THERAPEUTICS, INC.License Agreement • March 9th, 2017 • Dimension Therapeutics, Inc. • Biological products, (no disgnostic substances) • Pennsylvania
Contract Type FiledMarch 9th, 2017 Company Industry JurisdictionThis Research, Collaboration & License Agreement (this “Agreement”) is dated as of May 5, 2016 (the “Effective Date”) by and between The Trustees of the University of Pennsylvania, a Pennsylvania nonprofit corporation (“Penn”), and Dimension Therapeutics, Inc., a corporation organized under the laws of the state of Delaware (“Licensee”). Penn and Licensee may be referred to herein as a “Party” or, collectively, as “Parties”.
SPONSORED RESEARCH AND OPTION AGREEMENTSponsored Research Agreement • March 9th, 2017 • Dimension Therapeutics, Inc. • Biological products, (no disgnostic substances) • Pennsylvania
Contract Type FiledMarch 9th, 2017 Company Industry JurisdictionThis Sponsored Research Agreement (“Agreement”), effective as of January 1, 2015 (the “Effective Date”) is made by and between The Trustees of the University of Pennsylvania, a Pennsylvania nonprofit corporation (“Institution”), with offices located at The Penn Center for Innovation, 3160 Chestnut St., Suite 200, Philadelphia, PA 19104, and Dimension Therapeutics, Inc., a corporation organized under the laws of Delaware (“Sponsor”), having a place of business at 840 Memorial Drive, Cambridge, MA, 02139.